Anthropic announced that it will allocate 5% of its outstanding shares to a newly created Anthropic Public Benefit Fund, a pledge valued at about $48 billion based on a $965 billion pre‑IPO valuation.
The allocation must be approved by shareholders in the weeks leading up to the company’s anticipated November listing, and the fund’s share may rise by up to 2% for every 50% increase in Anthropic’s market value above an undisclosed baseline.
The company has not clarified whether the pledged shares will be newly issued, what the baseline valuation is, or how the fund intends to convert the equity into cash, leaving the mechanics of the benefit structure uncertain.
Analysts estimate that if the IPO reaches a $1.5 trillion valuation, the 5% stake could be worth roughly $75 billion, while a lower valuation of $144 billion would reduce the stake’s worth to about $7.2 billion.
The pledge signals a commitment to a public‑benefit mission, which could enhance Anthropic’s ESG profile and appeal to investors seeking socially responsible exposure, but the lack of detail on share issuance and conversion may introduce valuation uncertainty for prospective buyers.
This story was compiled by the Tradexus News Desk with the help of AI.
